From Name:
From Email:
To Name:
To Email:

Optional Message:

Biosimilars for Cancer Drugs Move Ahead

from 12/15/17, Drug Topics

Cancer patients may have more choice with their medications in the near future, as the FDA approved the first biosimilar to Herceptin (trastuzumab) for treating breast cancer and metastatic stomach cancer. In addition, a biosimilar to Neulasta (pegfilgrastrim), which boosts the white blood cell count during chemotherapy, garnered some positive Phase 1 study results. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063